Supernus Pharmaceuticals
Focus: Supernus Pharmaceuticals is a specialty pharmaceutical company focused on neurology small molecules based in Rockville, MD. The company is heavily dependent on GOCOVRI (amantadine), which represents 55% of revenue.
Profile data last refreshed 18h ago · AI intelligence enriched 1w ago
Open Jobs
0
3 recent layoff filings (12 mo) — 292 affected
- 2/27/2026 — 117 Waterworks Way Irvine CA 92618, CA · 58 affected · Layoff
- 2/27/2026 — CA · 176 affected · Layoff Amendment
- 2/27/2026 — CA · 58 affected · Layoff Amendment
Source: state DOL filings via Big Local News
About Supernus Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Supernus Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Supernus Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
2 imminent
OXTELLAR XR
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for Supernus Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.